• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食失调症的医疗服务利用情况及费用

The health service use and cost of eating disorders.

作者信息

Simon Judit, Schmidt Ulrike, Pilling Stephen

机构信息

Health Economics Research Centre, Department of Public Health, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK.

出版信息

Psychol Med. 2005 Nov;35(11):1543-51. doi: 10.1017/S0033291705004708.

DOI:10.1017/S0033291705004708
PMID:16219112
Abstract

BACKGROUND

The economic burden and health service use of eating disorders have received little attention, although such data are necessary to estimate the implications of any changes in clinical practice for patient care and health care resource requirements. This systematic review reports the current international evidence on the resource use and cost of eating disorders.

METHOD

Relevant literature (1980-2002) was identified from searches of electronic databases and expert contacts.

RESULTS

Two cost-of-illness studies from the UK and Germany, one burden-of-disease study from Australia and 14 other publications with relevant data from the UK, USA, Austria, Denmark and The Netherlands could be identified. In the UK, the health care cost of anorexia nervosa was estimated to be 4.2 million UK pounds in 1990. In Germany, the health care cost was 65 million Euro for anorexia nervosa and 10 million Euro for bulimia nervosa during 1998. The Australian study reported the health care costs of eating disorders to be Aus $22 million for year 1993/1994. Other costing studies focused mostly on in-patient care reporting highly variable estimates. There is a dearth of research on non-health care costs.

CONCLUSIONS

The limited available evidence reflects a general under-detection and under-treatment of eating disorders. Although both cost-of-illness studies may significantly underestimate the costs of eating disorders because of important omitted cost items, other evidence suggests that the economic burden is likely to be substantial. Comprehensive data on the resource use of patients with eating disorders are urgently needed for better estimations, and to be able to determine cost-effective treatment options.

摘要

背景

饮食失调的经济负担和卫生服务利用情况很少受到关注,尽管此类数据对于评估临床实践中的任何变化对患者护理和卫生保健资源需求的影响是必要的。本系统评价报告了目前关于饮食失调资源利用和成本的国际证据。

方法

通过检索电子数据库和联系专家确定了相关文献(1980 - 2002年)。

结果

可以确定来自英国和德国的两项疾病成本研究、来自澳大利亚的一项疾病负担研究以及其他14篇来自英国、美国、奥地利、丹麦和荷兰的包含相关数据的出版物。在英国,1990年神经性厌食症的卫生保健成本估计为420万英镑。在德国,1998年神经性厌食症的卫生保健成本为6500万欧元,神经性贪食症为1000万欧元。澳大利亚的研究报告称,1993/1994年饮食失调的卫生保健成本为2200万澳元。其他成本核算研究大多集中在住院护理方面,报告的估计值差异很大。关于非卫生保健成本的研究很少。

结论

现有的有限证据反映出饮食失调普遍存在检测不足和治疗不足的情况。尽管两项疾病成本研究可能因重要成本项目被遗漏而显著低估了饮食失调的成本,但其他证据表明经济负担可能很大。迫切需要关于饮食失调患者资源利用的全面数据,以便更好地进行估计,并能够确定具有成本效益的治疗方案。

相似文献

1
The health service use and cost of eating disorders.饮食失调症的医疗服务利用情况及费用
Psychol Med. 2005 Nov;35(11):1543-51. doi: 10.1017/S0033291705004708.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
4
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
7
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
10
Interventions for preventing eating disorders in children and adolescents.预防儿童和青少年饮食失调的干预措施。
Cochrane Database Syst Rev. 2002;2002(2):CD002891. doi: 10.1002/14651858.CD002891.

引用本文的文献

1
Prevalence and determinants of eating disorder risk behaviours among adult women in Denmark: findings from nationwide cross-sectional health surveys between 2000 and 2023.丹麦成年女性饮食失调风险行为的患病率及影响因素:2000年至2023年全国横断面健康调查结果
J Eat Disord. 2025 Jun 16;13(1):112. doi: 10.1186/s40337-025-01318-7.
2
"I mean, it kind of saved my life, to be honest": a qualitative study of participants' views of a dialectical behaviour therapy for multidiagnostic eating disorders programme.“说实话,这在某种程度上救了我的命”:一项关于参与者对多诊断饮食失调项目辩证行为疗法看法的定性研究。
J Eat Disord. 2024 Nov 20;12(1):186. doi: 10.1186/s40337-024-01142-5.
3
Global and Regional Economic Burden of Eating Disorders: A Systematic Review and Critique of Methods.
饮食失调的全球和区域经济负担:系统评价与方法批判
Int J Eat Disord. 2025 Jan;58(1):91-116. doi: 10.1002/eat.24302. Epub 2024 Nov 14.
4
Cost-effectiveness of specialist eating disorders services for children and adolescents with anorexia nervosa: a national surveillance study.针对神经性厌食症儿童和青少年的专科饮食失调服务的成本效益:一项全国性监测研究。
J Eat Disord. 2021 Jun 26;9(1):76. doi: 10.1186/s40337-021-00433-5.
5
Healthcare utilisation for eating disorders among patients with depression: a cross-sectional study in Taiwan.抑郁症患者饮食失调的医疗服务利用情况:台湾的一项横断面研究。
BMJ Open. 2019 Dec 29;9(12):e032108. doi: 10.1136/bmjopen-2019-032108.
6
Identifying Individuals with Eating Disorders Using Health Administrative Data.利用健康管理数据识别进食障碍患者。
Can J Psychiatry. 2020 Feb;65(2):107-114. doi: 10.1177/0706743719844183. Epub 2019 May 2.
7
Disaggregating the predictive effects of impaired psychosocial functioning on future DSM-5 eating disorder onset in high-risk female adolescents.解析心理社会功能障碍对高危女性青少年未来出现 DSM-5 饮食障碍的预测作用。
Int J Eat Disord. 2019 Jul;52(7):817-824. doi: 10.1002/eat.23082. Epub 2019 Apr 12.
8
Australian Healthcare Professionals' Knowledge of and Attitudes toward Binge Eating Disorder.澳大利亚医疗保健专业人员对暴饮暴食症的了解与态度。
Front Psychol. 2017 Aug 7;8:1291. doi: 10.3389/fpsyg.2017.01291. eCollection 2017.
9
The PED-t trial protocol: The effect of physical exercise -and dietary therapy compared with cognitive behavior therapy in treatment of bulimia nervosa and binge eating disorder.青少年饮食失调治疗(PED-t)试验方案:体育锻炼和饮食疗法与认知行为疗法相比对神经性贪食症和暴饮暴食症的治疗效果
BMC Psychiatry. 2017 May 12;17(1):180. doi: 10.1186/s12888-017-1312-4.
10
Cost evaluation of out-of-country care for patients with eating disorders in Ontario: a population-based study.安大略省饮食失调患者境外就医的成本评估:一项基于人群的研究。
CMAJ Open. 2016 Nov 3;4(4):E661-E667. doi: 10.9778/cmajo.20160057. eCollection 2016 Oct-Dec.